Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Zylox-Tonbridge Medical Technology Co., Ltd. Class H (2190) Stock Price & Analysis

3 Followers

2190 Stock Chart & Stats

HK$18.66-HK$0.33(-1.74%)
At close: 4:00 PM GMT+8
HK$19HK$20HK$21HK$22Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
HKD 18.50 - HKD 19.21
52-Week Range
HKD 17.10 - HKD 28.00
Previous Close
HKD 18.99
Volume
N/A
Average Volume (3M)
320.86K
Market Cap
HKD 6.54B
Enterprise Value
HKD 4.58B
Total Cash (Recent Filing)
HKD 1.48B
Total Debt (Recent Filing)
HKD 143.12M
Price to Earnings (P/E)
16.7
Beta
0.77
Next Earnings
Mar 25, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
May 27, 2026
Dividend Yield
1.93%

Bulls Say, Bears Say

Bulls Say

Profitability Inflection

The sharp improvement in revenue and net margin shows that the company has moved beyond its earlier loss-making period and is converting growth into earnings. If maintained, this stronger operating model can support internal investment, broaden commercial reach, and improve resilience over the next several quarters.

High Gross Margin

A gross margin near 72% indicates substantial value capture from the company’s interventional vascular and neurovascular device portfolio. Strong product economics can provide room to fund research, commercialization, and market expansion while helping protect profitability as the business scales.

Conservative Balance Sheet

Very low leverage gives Zylox-Tonbridge financial flexibility and reduces the burden of interest and refinancing obligations. A conservatively financed balance sheet can help the company sustain product development and commercialization spending while remaining better positioned to absorb operating volatility.

Bears Say

Limited Earnings Track Record

The recent profit improvement is encouraging, but several consecutive years of losses show that the business has not yet demonstrated stable performance through a full operating cycle. This history makes future earnings less predictable and increases the importance of sustaining recent revenue and margin gains.

Uneven Free Cash Flow

The return to positive free cash flow is a meaningful improvement, yet repeated prior deficits indicate variability in cash conversion, working capital, or capital spending. Continued inconsistency could constrain internally funded expansion and make reported earnings less dependable as a source of business financing.

Recovery Returns Not Fully Proven

Although return on equity has improved, its relatively modest level and history of negative returns indicate that the turnaround remains at an early stage. The company still needs to demonstrate that stronger profitability can persist and generate attractive returns across multiple reporting periods.

Zylox-Tonbridge Medical Technology Co., Ltd. Class H News

2190 FAQ

What was Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s price range in the past 12 months?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H lowest stock price was HK$17.10 and its highest was HK$28.00 in the past 12 months.
What is Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s market cap?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s market cap is HK$6.54B.
When is Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s earnings last quarter?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H released its earnings results on Aug 20, 2026. The company reported HK$0.666 earnings per share for the quarter.
Is Zylox-Tonbridge Medical Technology Co., Ltd. Class H overvalued?
According to Wall Street analysts Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s price is currently Undervalued.
Does Zylox-Tonbridge Medical Technology Co., Ltd. Class H pay dividends?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H pays an annual dividend of HK$0.252 which represents an annual dividend yield of 1.93%. See more information on Zylox-Tonbridge Medical Technology Co., Ltd. Class H dividends here
What is Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s EPS estimate?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zylox-Tonbridge Medical Technology Co., Ltd. Class H have?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H has 336,350,740 shares outstanding.
What happened to Zylox-Tonbridge Medical Technology Co., Ltd. Class H’s price movement after its last earnings report?
Zylox-Tonbridge Medical Technology Co., Ltd. Class H reported an EPS of HK$0.666 in its last earnings report. Following the earnings report the stock price went up 1.026%.
Which hedge fund is a major shareholder of Zylox-Tonbridge Medical Technology Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:2190
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology